Legend Capital was founded by China's Legend Holdings as a strategic venture arm and remains tightly integrated into the conglomerate's broader industrial and capital ecosystem, positioning itself as a technology-driven "industrial capital" investor that leverages Legend's manufacturing roots in ways few VCs can. The firm was the GP counterparty in China's first-ever RMB-denominated GP-led secondary transaction and has built a particularly deep, system-level franchise in healthcare through multiple dedicated RMB healthcare funds and a healthcare continuation vehicle backed by global secondaries capital.